CFDE Data Portal | Search DYDC2

	Label	Description
	DYDC2 associations Collection (Entity type)	Associations for DYDC2_associations
	DYDC2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	DYDC2 Gene (Entity type)	ENSG00000133665 - DPY30 domain containing 2
	KFGENEBIN:DYDC2-variant-count CUI gene has variants DYDC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE216043 10 V 0 CISPLATIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	KFGENEBIN:DYDC2-variant-count CUI Kfgenebin (Entity type)	A Kfgenebin
	GSE146854 bufexamac T cell 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147626 3 V 0 GLUTATHIONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 trametinib YAP 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

DYDC2 associations

Associations for DYDC2_associations

DYDC2 associations.tsv

A file from IDG as part of the Harmonizome project

DYDC2

ENSG00000133665 - DPY30 domain containing 2

KFGENEBIN:DYDC2-variant-count CUI gene has variants DYDC2

A Knowledge Graph Assertion from Kids First

GSE216043 10 V 0 CISPLATIN HUMAN UP

A Gene Set from LINCS

KFGENEBIN:DYDC2-variant-count CUI

A Kfgenebin

GSE146854 bufexamac T cell 0 v 2 human up

A Gene Set from LINCS

GSE147626 3 V 0 GLUTATHIONE HUMAN UP

A Gene Set from LINCS

GSE130401 trametinib YAP 1 v 0 human dn

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.